Skip to main content
SpringerLink
Log in

Cetuximab/cisplatin/docetaxel

Various toxicities: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Guigay J, et al. Long-term response in patient with recurrent oropharyngeal carcinoma treated with cetuximab, docetaxel and cisplatin (TPEx) as first-line treatment followed by cetuximab maintenance. Oral Oncology 68: 114-118, May 2017. Available from: URL: http://doi.org/10.1016/j.oraloncology.2017.03.009 - France

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cetuximab/cisplatin/docetaxel. Reactions Weekly 1658, 121 (2017). https://doi.org/10.1007/s40278-017-32318-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-32318-z

Search

Navigation